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The exonuclease Xrn1 activates transcription and
translation of mRNAs encoding membrane proteins
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The highly conserved 5’–3’ exonuclease Xrn1 regulates gene expression in eukaryotes by
coupling nuclear DNA transcription to cytosolic mRNA decay. By integrating transcriptome-
wide analyses of translation with biochemical and functional studies, we demonstrate an
unanticipated regulatory role of Xrn1 in protein synthesis. Xrn1 promotes translation
of a speciﬁc group of transcripts encoding membrane proteins. Xrn1-dependence for
translation is linked to poor structural RNA contexts for translation initiation, is mediated by
interactions with components of the translation initiation machinery and correlates with an
Xrn1-dependence for mRNA localization at the endoplasmic reticulum, the translation
compartment of membrane proteins. Importantly, for this group of mRNAs, Xrn1 stimulates
transcription, mRNA translation and decay. Our results uncover a crosstalk between the three
major stages of gene expression coordinated by Xrn1 to maintain appropriate levels of
membrane proteins.
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Proper tuning of protein levels under normal and perturbedconditions requires precise regulations at different stages ofgene expression. These stages, classically considered iso-
lated because of their different spatial and temporal incidence, are
indeed interconnected. A major crosstalk between transcription
and decay is mediated by Xrn11–3, a highly conserved exoribo-
nuclease, which is the 5ʹ–3ʹ messenger RNA (mRNA) degradation
enzyme in the cytoplasm4,5. Within the deadenylation-dependent
decay pathway, Xrn1 forms a complex interaction network with
the Dcp1/Dcp2 decapping enzyme and decapping activators, such
as Lsm1–7, Pat1, and Dhh1/DDX66,7. At least some of the
degradation activity of Xrn1 occurs co-translationally8. Xrn1
further participates in the decay of mRNAs after internal cleavage
and in the cytoplasmic mRNA surveillance system that degrades
aberrant mRNAs7. Moreover, Xrn1 directs degradation of long
non-coding RNAs and hypomodiﬁed transfer RNA (tRNA), as
well as maturation of ribosomal RNAs (rRNAs)7,9–12.
Remarkably, besides these exonucleolytic functions, Xrn1 acts
as a transcriptional activator. Xrn1, together with other compo-
nents of the deadenylation-dependent mRNA decay pathway,
shuttles between the cytoplasm and the nucleus, where they bind
to transcription start sites and directly stimulate transcription
initiation and elongation of many yeast genes1. The functions of
Xrn1 in both cellular compartments are linked. Shuttling of Xrn1
and other decay factors to the nucleus depends on the proper
exoribonucleolytic activity of Xrn1. By connecting mRNA
synthesis to decay, Xrn1 maintains mRNA homeostasis, as defects
in 5ʹ–3ʹ mRNA decay are buffered by reductions in mRNA
synthesis. Whether Xrn1 functions in other stages of gene
expression has not been considered.
Here, we show that Xrn1 acts as a translational modulator.
This unanticipated function is restricted to speciﬁc groups of
genes enriched in distinct GO terms. Interestingly, Xrn1 activates
both translation of mRNAs encoding membrane proteins and
their localization at the endoplasmic reticulum, the translation
compartment of membrane proteins. These mRNAs contain long
and highly structured 5ʹUTRs. A physical and functional inter-
action of Xrn1 with the translation initiation factor eIF4G is
required for translational activation, likely to overcome these
unfavorable contexts for translation initiation. Remarkably, the
group of mRNAs that depend on Xrn1 for translation highly
depend on Xrn1 for transcription and decay. Moreover, these
three functions of Xrn1 are linked. Our results show a coordi-
nated control of the three main stages of gene expression by Xrn1
to maintain proper homeostasis of membrane proteins. This
coordination may be important to prevent their toxic aggregation.
Results
Xrn1 drives translation of Brome mosaic virus RNA2. Given
the multifunctional nature of Xrn1 and its association with
translating mRNAs during co-translational decay, we examined
whether Xrn1 in addition regulates translation. As a ﬁrst
approach, we used the Brome mosaic virus (BMV)/yeast system.
The ability of the plant BMV RNA2 genome to translate in yeast
is a useful tool to identify and characterize specialized transla-
tional control mechanisms of host mRNAs13,14. The 5ʹcapped
BMV RNA2 contains a tRNA-like structure instead of a poly(A)
tail at the 3´end. Its long and structured 5ʹUTR and coding
sequence (CDS) contain cis-sequences involved in translational
control13,15. When expressed in yeast, RNA2 is recognized by the
ribosomes to translate the viral 2a polymerase. The complete
BMV lifecycle occurs within the cytoplasm. However, as we were
interested in identifying translational control mechanisms
affecting cellular mRNAs, we expressed the RNA2 from a cellular
promoter. We transformed wild-type (WT) yeast and an isogenic
XRN1 deletion strain (xrn1Δ) with a plasmid expressing BMV
RNA2 by the GAL1 promoter, whose transcription is activated by
Xrn1. Interestingly, whereas the steady-state level of the viral
RNA2 was increased in xrn1Δ cells, expression of the 2a protein
was substantially decreased (Fig. 1a). Translatability of RNA2
(change in 2a protein level divided by change in RNA2 level) in
xrn1Δ was only 0.4% of that in the WT. In xrn1Δ cells the
majority of mRNA molecules are capped16 and a major fraction
of uncapped mRNAs is associated to polyribosomes. Similarly, we
found that most of RNA2 molecules (77%) are capped (Supple-
mentary Fig. 1). In our calculations, we used total RNA2 instead
of capped RNA2 as the difference in the obtained values is
minimal. Translatability of RNA2 in xrn1Δ cells when consider-
ing only capped RNA2 is 0.5% instead of 0.4%. To determine
quantitatively whether the Xrn1 effect on 2a protein levels
involves protein degradation, we fused 2a to Renilla luciferase
(2a-Rluc). Turnover of 2a-Rluc was determined by blocking
translation with cycloheximide and measuring luciferase activity
thereafter. Whereas translatability of the chimeric mRNA was
affected by deleting XRN1 (Supplementary Fig. 2a), the 2a-Rluc
protein turnover was not (Supplementary Fig. 2b). We conclude
that Xrn1 promotes translation of RNA2.
To assess which regions of BMV RNA2 confer Xrn1-dependence
for translation, we replaced different RNA2 sequences and
quantiﬁed 2a and RNA2 levels in the presence or absence of
Xrn1. The 5ʹUTR was replaced by the GAL1 5ʹUTR and the non-
polyadenylated 3ʹUTR by the polyadenylated 3ʹUTR of the ADH1
transcript14 (Fig. 1b). These changes affected both protein and
RNA levels. Replacement of RNA2 3ʹUTR with ADH1 3ʹUTR had
no effect on translatability (Fig. 1b, lane 6). However, the 5ʹUTR
played an important role on the capacity of Xrn1 to affect
translatability (Fig. 1b, lane 8). Replacement of RNA2 CDS with
GFP CDS had a modest effect on translatability (Fig. 1b, lane 10).
Taken together, results in Fig. 1b indicate that the 5ʹ UTR is the
most Xrn1-responsive region in RNA2.
To investigate which step of BMV RNA2 translation is
stimulated by Xrn1, we performed polysome-proﬁling analyses
in WT and xrn1Δ cells expressing RNA2. Consistently with
previous studies17, the global rRNA proﬁle, indicative of the
global translation, was only mildly affected in xrn1Δ (Fig. 2a).
Northern blot analyses along the polysome proﬁle showed that
deletion of XRN1 shifted RNA2 toward monosomal, 60s and 40s
fractions (Fig. 2b), suggesting a role of Xrn1 in translation
initiation. In agreement with the known dependence of
polysomes on the presence of Mg2+, EDTA treatment shifted
BMV RNA2 from heavy polysomes to lighter fractions (Supple-
mentary Fig. 3). To further strengthen the link of Xrn1 to
translational control, we examined whether Xrn1 co-sediments
with ribosomes in polysome proﬁling. We observed an enrich-
ment of Xrn1 in fractions corresponding to 40s subunits (Fig. 2c).
Collectively, these results indicate that Xrn1 is required for
efﬁcient translation of RNA2, likely at early events of the
translation initiation step.
The effect of Xrn1 on BMV RNA2 translation is speciﬁc. Stably
deleting XRN1 can lead to selection of adaptive secondary muta-
tions that might cause indirect effects. To overcome this potential
limitation, we fused Xrn1 to an auxin-inducible degron (AID) that
induces rapid degradation of Xrn1 and measured the immediate
effects18. AID-tagging of Xrn1 did not signiﬁcantly affect its func-
tion in BMV RNA2 translation (Supplementary Fig. 4). WT cells
carrying AID-tagged XRN1 in its natural genomic locus and a
plasmid expressing RNA2-Rluc from a GAL1 promoter were
grown in rafﬁnose to logarithmic phase. Addition of galactose and
auxin resulted in simultaneous induction of BMV RNA2-Rluc
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transcription and Xrn1-AID depletion (Fig. 3a). Xrn1-AID protein
levels decreased upon addition of auxin and were no longer
detected after 35min (Fig. 3b) while global translation was not
affected at this time-point (Fig. 3c). Induction kinetics of RNA2-
Rluc was comparable in WT and xrn1Δ (Fig. 3d), probably due to
the compensatory effect of transcription and decay of this
transcript. In contrast, the level of 2a-Rluc protein, which reﬂects
mainly translation at these early time-points after galactose induc-
tion, was reduced in auxin-treated cells (Fig. 3e). The effect of Xrn1-
AID depletion was observed already at early time-points after auxin
addition, indicating that depletion of Xrn1 inhibits RNA2 transla-
tion immediately and that an indirect effect is unlikely.
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Fig. 1 Xrn1 drives translation of BMV RNA. a Xrn1 depletion inhibits BMV RNA2 translation. Simultaneously exposed western blot and northern blot panels
showing steady-state levels of viral protein 2a and RNA2. b The BMV RNA2 5ʹUTR and CDS confer dependence on Xrn1 for translation. Black solid lines
represent viral UTRs and orange lines GAL1 mRNA 5ʹ and ADH1 3ʹUTRs. The white and green boxes represent 2a and GFP CDSs, respectively. Throughout
this study, BMV RNA2 was expressed from a plasmid by the GAL1 promoter, PGK protein, and 18 S RNA were used as loading controls for western and
northern blots, respectively. Values denote expression relative to WT, taken arbitrarily as 100% and are calculated from n= 3 independent colonies and
expressed as mean ± SEM. Dotted lines represent a separation of the shown samples in the same membrane. Open circles indicate the individual data
points. Source data are provided as a Source Data ﬁle
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Next, by replacing Xrn1 with its nuclear paralog Rat1 we
explored whether the positive role of Xrn1 in translation is
speciﬁc. When forced to localize in the cytoplasm by deleting its
nuclear localization signal (NLS), Rat1ΔNLS functionally replaces
Xrn119. Accordingly, expression of Rat1ΔNLS in xrn1Δ cells fully
rescued viral RNA2 degradation and cellular growth (Fig. 4a). In
contrast, Rat1ΔNLS did not efﬁciently rescue translation of BMV
RNA2, since, upon addition of Rat1ΔNLS to xrn1Δ cells, the
expression of protein 2a was only marginally recovered (Fig. 4b).
Hence, viral RNA2 translation requires an Xrn1-speciﬁc function,
not simply its 5ʹ to 3ʹ exonuclease activity per se.
As our polysome-proﬁling results suggested a role of Xrn1 in
translation initiation (Fig. 2b), we examined whether Xrn1
interacts with the eIF4F complex, a key component of the
translation initiation machinery that binds to capped mRNA and
mediates its interaction with the 43S pre-initiation complex20.
This complex consists of the RNA helicase eIF4A, the cap-
binding proteins eIF4E and the large eIF4G scaffold protein. We
carried out immunoprecipitation assays using yeast strains
carrying functionally validated genomic GFP-tag fusions of
eIF4G, eIF4A, or eIF4E transformed with plasmids expressing
FLAG-tag fusions of Xrn1 or Rat1ΔNLS (Fig. 4c and Supple-
mentary Figs. 5 and 6). Remarkably, Xrn1, but not Rat1ΔNLS,
co-immunoprecipitated with eIF4G in an RNase-resistant
manner. Neither Xrn1 nor Rat1ΔNLS interacted with eIF4A
while RNase-sensitive interactions with eIF4E were detected for
both Xrn1 and Rat1ΔNLS. Thus, Xrn1, but not Rat1ΔNLS,
interacts with eIF4G. To test whether the ability of Xrn1 to
interact with eIF4G is functionally linked to its role in translation
we designed a gain-of-function experiment. The sequence and
folding of the N-terminal exonuclease domains of Rat1 and Xrn1
are very similar. However, Rat1 lacks an unstructured C-terminal
domain present in Xrn1 that serves as an interaction platform in
higher eukaryotes21. We used structural modeling to generate a
chimera between the Rat1ΔNLS N-terminal domain and the
Xrn1 C-terminal tail (Rat1ΔNLS-XC, Supplementary Fig. 7a, b)
and tested its expression (Supplementary Fig. 6) and function-
ality (Supplementary Fig. 7c). As found for Rat1ΔNLS, the
chimeric protein rescued cellular growth in xrn1Δ cells
indicating that the fusion of the Xrn1 C-terminal tail does not
compromise the global function of Rat1ΔNLS. Expression of
Rat1ΔNLS-XC resulted in a twofold increase of viral 2a
expression when compared to Rat1ΔNLS (Fig. 4d) while the
steady-state levels of RNA2 were similar. Notably, the
Rat1ΔNLS-XC chimera concomitantly gained interaction with
the translation initiation factor eIF4G (Fig. 4e). Consistently, in
comparison to wild-type Xrn1, expression of Rat1ΔNLS shifted
RNA2 from light polysomes to 40s and 60s fractions in
polysome-proﬁling experiments. This shift was partially abro-
gated when Rat1ΔNLS-XC was expressed (Supplementary
Fig. 8a). Overall our data suggest a speciﬁc function of Xrn1 in
translation mechanistically linked to its C-terminal domain and
the ability to interact with eIF4G.
Xrn1 drives translation and localization of secretome mRNAs.
Our results using the BMV RNA2 model in yeast prompted us to
investigate whether Xrn1 also regulates translation of cellular
mRNAs. We used the Xrn1-AID degron system to avoid adaptive
effects and studied genome-wide translational changes using
ribosome-proﬁling. This method is based on the isolation and
deep-sequencing of ribosome-protected fragments (RPFs) and
WT
xrn1
Polysomes80S
40S 60SA
bs
 2
60
 n
m
10% 50%Sucrose  gradient
Ab
s 
26
0 
nm 80S
60S
40S
Polysomes
10% 50%Sucrose gradient
s 4 5 6 7 8 9 10 11 12 13 14 15 P
Xrn1
S8
L1
s 4 5 6 7 8 9 101112131415 P (kDa)
181.8
19.4
25.9
80
60
40
20
0
%
 To
ta
l R
N
A2
WT
xrn1
1–5 6–11 12–15 16–21 22–26
Fractions
WT
xrn1Δ
Fractions 1–5 6–11 12–15 16–21 22–26
a
b
c
Fig. 2 Xrn1 depletion shifts RNA2 toward single ribosomal subunits fractions. a ultraviolet (UV) absorbance rRNA proﬁle at 260 nm of an extract from WT
and xrn1Δ cells expressing RNA2 after sedimentation on a 10 to 50% sucrose gradient. b Depletion of Xrn1 shifts BMV RNA2 toward monosomal fractions.
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n= 3 biological replicates. Error bars represent SEM. Open circles indicate the individual data points. Lower panel: representative northern blots. c Xrn1
cofractionates with free 40s subunits in polysome-proﬁling analysis. Top panel: UV absorbance rRNA proﬁle at 260 nm of an extract from WT cells. Lower
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parallel transcriptome analysis22. Ribosome-proﬁling was per-
formed on samples before and after 30 min of auxin treatment
(Fig. 5a). Replicates of the RPF and RNAseq libraries clustered in
principal-component analyses (Supplementary Fig. 9). To identify
genes showing changes of translational efﬁciency upon degron-
mediated Xrn1 knock-down (Xrn1-KD), we used the Riborex
R-package23, which assesses whether changes of ribosome occu-
pancy could be explained by changes of the corresponding
mRNA. Genes were plotted according to their log2-fold changes
in mRNA abundance and ribosome occupancy (RPF) (Fig. 5b). A
majority of genes showed no signiﬁcant changes in translational
efﬁciency. Strikingly, we identiﬁed a speciﬁc set of genes trans-
lationally activated (445) or repressed (597) by Xrn1. Genes
showing signiﬁcant alterations of translational efﬁciency (FDR <
0.05) were grouped according to their relative mRNA and RPF
log2 fold changes (log2FC, obtained via DESeq2). If mRNA levels
changed within a range of approximately ± 35%, they were con-
sidered as stable/buffered (similar to ref. 13), (Fig. 5b and Sup-
plementary Data 1). We classiﬁed genes with reduced
translatability upon Xrn1 depletion (Xrn1-KD) as translationally
activated by Xrn1 whereas translationally repressed genes corre-
spond to those with increased translatability. Using these criteria,
we obtained ﬁve different classes of genes that were subsequently
tested for functional enrichment via gene ontology (GO) terms.
Importantly, three of these groups showed distinct and highly
signiﬁcant functional enrichments. (I) translationally activated
genes whose mRNA levels are buffered (red) were enriched for
genes related to glycosylation, membranes and ER, (II) transla-
tionally repressed genes with buffered mRNA levels (green) were
related to proteasome function and protein folding, and (III)
translationally repressed genes with decreased mRNA levels
(orange) showed enrichment for cytoplasmic translation and
ribosomes (Fig. 5c and Supplementary Data 2). These results
revealed that Xrn1-dependent regulation characterizes at least
three different groups of genes, which are deﬁned by different
behaviors in RNA steady-state levels and translation, and are
enriched for different cellular functions.
The absence of Xrn1 can lead to accumulation of uncapped
mRNAs that are normally degraded by Xrn1 (see Supplementary
Fig. 1), which might affect our results. However, as we observe for
RNA2, most of the mRNAs are capped in xrn1Δ cells16. The
minor fraction of deadenylated and uncapped mRNAs is mainly
associated to polyribosomes16 and thus are captured by the
ribosome-proﬁling libraries but are depleted from the oligo(dT)-
selected RNAseq libraries. Thus, the activating effects of Xrn1 on
the translationally activated mRNAs would be slightly higher than
our estimates, while the repressing effects on the translationally
repressed mRNAs would be slightly lower.
The cytosol and the ER represent distinct biological environ-
ments for translation with different regulatory factors. As
membrane proteins are translated and glycosylated at the ER,
we questioned whether Xrn1-dependence for translation is linked
to a possible role of Xrn1 in localizing the affected mRNAs to the
ER. Based on our Ribosome-proﬁling data, we selected three
groups of transcripts: (i) transcripts encoding membrane proteins
that depend on Xrn1 for translation and, as controls, (ii)
transcripts encoding membrane proteins that do not depend on
Xrn1 for translation, and (iii) transcripts encoding cytosolic
proteins. Next, we isolated ER membranes from the cytosol and
quantiﬁed the relative amounts of the selected transcripts
associated to ER and cytosol in WT as compared with that in
Xrn1-KD cells (Fig. 5d). Transcripts that depend on Xrn1 for
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translational activation exhibited a fourfold increase in ER
localization when Xrn1 was present while transcripts that do
not depend on Xrn1 for translation exhibited a twofold increase.
No such effect was observed for cytosolic transcripts. Membrane
proteins (as deﬁned in ref. 24) were enriched among the Xrn1-
dependent transcripts of our ribosome-proﬁling data as
Xrn1-activated transcripts were 2.09 times more likely to be part
of the membrane compared to transcripts that do not depend on
Xrn1 for translation. In contrast, transcripts that were transla-
tionally repressed upon Xrn1-KD were devoid of membrane
genes (Supplementary Data 3). Considering that our current
subset of Xrn1-activated genes represents a stringent selection of
mRNA levels
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Xrn1-dependent events, our analysis might miss transcripts
affected by Xrn1 depletion (false negatives). Based on the
observed behavior of membrane genes among transcripts that
are translationally controlled by Xrn1, many of these false
negatives can be anticipated to be membrane genes as well. This
might explain the twofold increase in ER localization observed in
mRNAs encoding membrane proteins classiﬁed as not dependent
on Xrn1.
We conclude that Xrn1-KD cells are defective in recruiting
mRNAs to the ER while the extent of this defect correlates with
the capacity of Xrn1 to activate translation. As this defect was
observed shortly after Xrn1 depletion, it is unlikely an indirect
effect of the absence of Xrn1. The described routes of targeting
mRNAs to the ER for translation include signal recognition
particle (SRP)-dependent and -independent pathways. Based on
previous studies24,25 we found that both SRP-dependent and
-independent transcripts are similarly represented in the
transcripts encoding membrane proteins whose translation is
activated by Xrn1. This argues in favor of Xrn1 functioning along
both routes.
Xrn1-activated mRNAs have long and structured 5ʹUTRs. Next,
we investigated whether mRNAs regulated by Xrn1 share com-
mon physical properties. First, we calculated the average length of
the 5ʹUTRs, CDSs and 3ʹUTRs for the three groups and compared
them to all genes that were not signiﬁcantly altered (Fig. 6a and
Supplementary Data 4a–d). Xrn1-activated mRNAs had sig-
niﬁcantly longer 5ʹUTRs (80 nt) and CDS (1555.5 nt) when
compared to transcripts not signiﬁcantly altered (52 and 1113 nt).
In contrast, Xrn1-repressed mRNAs had shorter 5ʹUTRs (mRNA
buffered: 44; mRNA decreased: 35.5 nt) and CDS (mRNA
buffered: 753; mRNA decreased: 600 nt) compared to not sig-
niﬁcantly altered transcripts, whereas only repressed genes
with buffered mRNA levels showed an increased 3ʹUTR length
(128 nt) compared to background genes (105 nt). Interestingly, as
for the cellular Xrn1-activated mRNAs, BMV RNA2 contains
long 5ʹUTRs and CDS (92 nt and 2468 nt). Second, as BMV
RNA2 5ʹUTR contains highly structured sequences, we examined
whether this feature also characterizes the cellular Xrn1-activated
mRNAs and extended this analysis to the CDS. We used
previously published datasets of genome-wide RNA secondary
structure obtained by PARS (Parallel Analysis of RNA
structure)26 to analyze the RNA structure proﬁle in the 5ʹUTRs,
CDSs and 3ʹUTRs. PARS scores are based on deep-sequencing of
RNA fragments obtained by RNA digestion with enzymes that
exhibit structural preferences. While there were no substantial
differences in the 3ʹUTR, all groups of transcripts regulated by
Xrn1 had a signiﬁcantly higher PARS score in the CDS
(0.32–0.35) compared to transcripts not signiﬁcantly affected by
Xrn1 (0.25) (Fig. 6b). Importantly, only activated transcripts had
a higher structured 5ʹUTR (0.16) compared to transcripts not
signiﬁcantly affected (0.06). Repressed genes, whose mRNA levels
decreased due to depletion of Xrn1, exhibited the lowest structure
of the 5ʹ-UTRs (0.03). These differences are more visible when
plotting the PARS score distribution (Fig. 6c). Note, in particular,
that the PARS score drops around the translation initiation sites
(TIS) (Fig. 6c). This relatively unstructured region has probably
evolved to permit an easy access to the ribosome at the canonical
translation initiation site, and may contribute to the recognition
of true start sites26,27. Interestingly, Xrn1-activated mRNAs have
a substantially higher PARS score at the TIS and their upstream
regions, suggesting that one of the Xrn1 functions is to override
the structural barrier at the TIS. Notably, we found that long
5ʹUTRs and CDSs and highly structured 5ʹUTRs with unfavorable
contexts for translation initiation are indeed common features for
mRNAs encoding membrane proteins (as deﬁned in ref. 24).
Remarkably, those mRNAs identiﬁed to depend on Xrn1 for
translation show the highest PARS scores (Supplementary
Fig. 10).
To further understand the role of Xrn1 in translational
regulation, we questioned whether the changes observed in
ribosome occupancy in activated transcripts were due to
changes in initiation and/or elongation. Ribosome-proﬁling
can detect defects in speciﬁc translation steps because discrete
ribosome pausing increases the likelihood of capturing
footprints in the pausing site by deep-sequencing. Therefore,
defects in elongation caused by ribosome stalling result in a
peak in ribosome density and an accumulation of ribosomes
upstream of the stalling site. This would be visible as a change
in slope in a metagene analysis, with the 5ʹ end showing an
increased footprint density and the 3ʹ end showing a decrease.
In contrast, differences in translation initiation result in a shift
of ribosome occupancy along the entire CDS. To distinguish
between these two possibilities, we examined the relative RPF
distribution along the CDS of the three mRNA groups deﬁned
previously and compared them to genes that did not show any
signiﬁcant alterations (Fig. 6d). In agreement with a role of
Xrn1 in translation initiation, activated genes exhibited a
general reduction of footprint density while repressed genes
exhibited a general increase. Collectively, we conclude that long
5ʹUTRs and CDSs and highly structured 5ʹUTRs are common
features of both BMV RNA2 and cellular transcripts that
depend on Xrn1 for translation. This suggests a common role
for Xrn1 in regulating translation of cellular mRNAs and BMV
RNA2, likely at the translation initiation step.
Fig. 5 Xrn1 acts as a translational regulator of cellular mRNAs. a Experimental set-up used for ribosome-proﬁling analysis. Two duplicates for each
condition (no auxin and 30min with auxin) were included (n = 2). Western blot analysis corroborated Xrn1 depletion upon auxin addition. b Analysis of the
results from the RNAseq and RPF libraries, comparing untreated cells (WT) to auxin-treated cells (Xrn1-KD). Log2 fold changes in mRNA abundance and
ribosome occupancy (RPF) are represented. Vertical dashed lines in black depict the thresholds chosen to consider mRNA levels as stable/buffered ((log2
fold change) < 0.433); see ref. 13). A perfect correlation between changes in mRNA and ribosome occupancy levels is indicated by a dashed diagonal line.
Gray dots correspond to genes with no signiﬁcant change in translational control (Riborex FDR≥ 0.05). Colored dots correspond to genes that show
signiﬁcant changes in translational regulation upon Xrn1 depletion (Riborex FDR < 0.05). These genes are classiﬁed into ﬁve different subgroups according
to their behavior in terms of mRNA and RPF changes. c Gene ontology enrichment analysis (GSEA) of transcripts translationally regulated by Xrn1, focusing
on Biological Process and Cellular Component. Colors correspond to the same groups of genes as described in Fig. 5b. At most ﬁve signiﬁcant terms after
Revigo redundancy removal are depicted (ordered by p-value). d Xrn1-dependence for translation correlates with Xrn1-dependence for ER localization. The
y-axis indicates the ER localization:cytosol-localization in WT (no auxin) related to Xrn1-depleted cells (30min of auxin treatment). The ratio of speciﬁc
mRNAs between supernatant and membrane fractions was calculated in WT and xrn1Δ conditions. Xrn1-dependence for ER localization was calculated by
dividing [(cc/cm) xrn1Δ]/[(cc/cm) WT] (cc= conc. in the cytosol fraction; cm= concentration in the membrane fraction). The values were represented
relative to TUB2, which was set to 1. Open circles indicate the individual data points. Values are the mean of n= 3 assays ± SEM. Statistical signiﬁcance was
calculated using a Student’s t-test (***p-value < 0.001). Source data are provided as a Source Data ﬁle
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The distinct functions of Xrn1 in gene expression are linked.
To examine whether the function of Xrn1 in translation is linked
to its known roles in transcription and decay, we determined the
effect of Xrn1 on the transcription and decay of those mRNAs
that are translationally activated by Xrn1. To obtain a whole-
genome view of transcription rates (TRs), we performed genomic
run-on experiments (GRO)28 in the Xrn1-AID degron system
30min after auxin addition. In parallel with GRO analysis, we
determined the mRNA steady-state levels, which allowed us to
calculate mRNA half-lives2. Reassuringly, we found that depletion
of Xrn1 for 30 min had a similar effect on transcription rates to
that previously observed in xrn1Δ strain1,2. The GO categories
(Supplementary Data 5) enriched in genes transcriptionally
activated (ribosome biogenesis, translation) or repressed (mito-
chondria, respiration) by Xrn1 were similar to those observed
when Xrn1 is permanently depleted although quantitatively
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lower, suggesting that permanent depletion of Xrn1 intensiﬁes
this phenotype. Likewise, the distinction between the Xrn1 Syn-
thegradon group, which is highly responsive to XRN1 disruption,
and the anti-Synthegradon group, which contains the least
responsive genes2, was clearly visible upon Xrn1-AID depletion
(Supplementary Fig. 11). Importantly, within the groups of
mRNAs translationally regulated by Xrn1, the translationally
activated one showed signiﬁcantly decreased transcription rates
and increased half-lives upon Xrn1 depletion (Fig. 7a, b=
mRNA, red). Thus, Xrn1 stimulates mRNA synthesis, translation,
and decay of this group of mRNAs.
Next, we investigated whether these three Xrn1-driven
functions are linked. If this is the case, defects in one function
should affect the others. To address this key issue, we made use of
the catalytically inactive xrn1D208A mutant. This mutant binds
decapped mRNAs but is unable to degrade them and becomes
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trapped in an RNA-bound state29,30. Consequently, the nuclear
import of Xrn1, and other mRNA decay factors whose import
depend on Xrn1, is impaired1,31. Replacing XRN1 at its genomic
locus by XRN1D208A results in transcription and decay defects
comparable to those in xrn1Δ cells1. We reasoned that if the
function of Xrn1 in translation, transcription and decay are
linked, xrn1D208A mutation should also impair Xrn1-dependent
translation. Ribosome-proﬁling analyses of the xrn1D208A mutant
identiﬁed a group of cellular mRNAs that depend on Xrn1 for
translation. These mRNAs were enriched for cellular functions
related to protein glycosylation and membrane localization
(Supplementary Data 6) and signiﬁcantly overlapped with those
identiﬁed with the Xrn1-AID system (p-value= 1.4e−29, Hyper-
geometric test). Moreover, xrn1D208A mutation inhibited BMV
RNA2 translation like XRN1 deletion (Fig. 7c). Similarly, a
catalytically inactive version of Rat1ΔNLS-XC (Rat1ΔNLS-XC-
D235A) inhibited RNA2 translation (Supplementary Fig. 8a, b).
To obtain further insights into the linkage between the three
functions of Xrn1, we uncoupled RNA2 translation from
transcription. We reasoned that if Xrn1-dependent translation
requires a previous function of Xrn1 in transcription, introducing
RNA2 directly into the cytosol would result in an Xrn1-
independent translation of RNA2. To test this, we electroporated
in vitro transcribed RNA2-Rluc into WT and xrn1Δ cells together
with an mRNA control expressing Fireﬂy-luc for normalization
(Fig. 7d). Remarkably, in contrast to the inhibition of 2a protein
expression observed in xrn1Δ when RNA2 was expressed from a
plasmid (Fig. 1a), deletion of XRN1 did not inhibit 2a protein
expression (Fig. 7d). Instead, we observed an increase in the
expression of 2a protein consistent with an extended RNA2 half-
life (Fig. 4a), indicating that the linkage between transcription
and post-transcriptional stages was broken by circumventing
transcription and introducing mRNAs by electroporation.
Altogether, we conclude that the functions of Xrn1 in synthesis,
translation, and decay of the translationally activated mRNAs are
linked.
Discussion
In this study, we reveal an unanticipated role for the major 5ʹ–3ʹ
exonuclease Xrn1 in both activating translation of mRNAs
encoding membrane proteins and in directing these mRNAs to
the ER, their translation site. Remarkably, for this group of
mRNAs Xrn1 activates translation, transcription and decay, and
these functions are linked. Our results uncover a crosstalk
between the three major processes of gene expression coordinated
by Xrn1 to express membrane proteins.
A number of observations are consistent with a speciﬁc role of
Xrn1 in translation initiation. First, transient depletion of Xrn1
has an immediate inhibitory effect on RNA2 translation. Con-
sequently, a selection of adaptive mutations that may account for
the observed translation effects seems unlikely (Fig. 3d, e). Sec-
ond, Rat1ΔNLS, the nuclear paralog of Xrn1 retained in the
cytoplasm due to the deletion of its NLS, fully rescues
RNA2 stability (Fig. 4a), but not RNA2 translation (Fig. 4b).
These data argue against the possibility that changes in mRNA
abundance driven by Xrn1 depletion are responsible for the
observed translation defects. It has been reported that Xrn1
depletion causes changes in the formation of RNA duplexes that
result from transcription of convergent genes and affect their
protein expression levels32. Our ribosome-proﬁling data show,
however, no enrichment for convergent genes. Third, polysome-
proﬁling analyses demonstrate that, upon Xrn1 depletion, BMV
RNA2 shifts from polysomes to monosomes (Fig. 2b) and
ribosome-proﬁling analyses show a decrease in the footprint
density along the CDSs of cellular mRNAs that are translationally
activated by Xrn1 (Fig. 6d). These features are consistent with
effects in translation initiation. The co-fractionation of Xrn1 with
40s ribosomal subunits would point to a role of Xrn1 in early
translation initiation events (Fig. 2c). Fourth, Xrn1 but not
Rat1ΔNLS interacts genetically33, physically, and functionally
(this study) with the translation initiation factor eIF4G. This was
shown by immunoprecipitation analyses (Fig. 4c, d) and gain-of-
function studies in which the C-terminal domain of Xrn1, the
only domain not present in Rat1, was fused to Rat1ΔNLS
(Fig. 4d). This domain is highly disordered and includes short
linear motifs (SLiMs), features typical of protein sequences with
capacity to bind multiple interacting partners34. Such motifs also
characterize the Xrn1 homologs in Homo sapiens and Drosophila
melanogaster6. Last, the mRNAs whose translation is activated by
Xrn1 have an unfavorable translation initiation context. They
contain long and highly structured 5ʹUTRs as demonstrated by
PARS scoring for host mRNAs and by functional studies for
RNA226,35. Typically, PARS scores drop immediately upstream of
the translation initiation site to favour translation initiation. In
contrast, the mRNAs that are translationally activated by Xrn1
exhibit an unusual high PARS score in this region, suggesting that
one function of Xrn1 is to overcome this impediment. Reassur-
ingly, replacement of the highly structured 5ʹUTR in RNA2
resulted in a 35-fold increase of translatability in WT cells and a
13-fold decrease in Xrn1-dependence (Fig. 1b).
Xrn1 coordinates a linkage between transcription, translation,
and decay for a speciﬁc group of mRNAs enriched in transcripts
encoding membrane proteins. We surmise that this linkage has
evolved to control proper gene expression of membrane proteins.
These proteins contain hydrophobic domains with strong ten-
dencies to aggregate. Consequently, their expression levels and
localization must be ﬁnely tuned to avoid aggregations that might
be toxic. Indeed, mRNAs related to vacuole transport in yeast and
the endomembrane system in Arabidopsis thaliana are among the
most frequently co-translationally degraded by Xrn18,36. This
feedback mechanism would ensure that Xrn1-dependent mRNAs
are efﬁciently translated only when decay is working properly.
The decision to express a gene, or a family of genes, is obtained by
crosstalks between all major stages of the mRNA lifecycle. For
example, it is counterproductive to transcribe a gene if the
translation apparatus is not capable of translating it. One
mechanism to permit these crosstalks is by factors that function
in all these stages. Xrn1 seems to carry this function. Another
example is Rpb4/7, that also acts in transcription, mRNA export,
translation, and decay37. Interestingly, XRN1 and RPB7 interact
genetically38, raising the possibility that they function in a coor-
dinated manner. One advantage for the cell of using factors that
function in all stages of the mRNA lifecycle is the ability to
regulate the synthesis and functionality of mRNAs by regulating
these factors.
In our study, we also identiﬁed two subsets of mRNAs trans-
lationally repressed by Xrn1. One of them is enriched for func-
tions related to proteasomal degradation and protein folding
(Fig. 5c). This hints to a crosstalk of mRNA biogenesis and
turnover with protein degradation. The other subset of mRNAs is
enriched for functions related to translation and ribosomes.
Interestingly, these mRNAs are the most dependent on Xrn1 for
transcription and decay at optimal growth conditions2. This
would allow a precise control of the global translation, the most
energy consuming cellular process. Although the mechanistic
details of Xrn1 function in translation repression are unclear, our
data indicate that it is context dependent (Fig. 6a–c) and, in the
case of repressed mRNAs, not linked to transcription and decay
activation (Fig. 7a, b).
Based on our observations, we propose a model wherein Xrn1
promotes translation initiation of mRNAs with unfavorable
NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-019-09199-6 ARTICLE
NATURE COMMUNICATIONS |         (2019) 10:1298 | https://doi.org/10.1038/s41467-019-09199-6 | www.nature.com/naturecommunications 11
translation initiation contexts by interacting with eIF4G and
stabilizing the interaction of the scanning 40s subunit with the
mRNA. As eIF4G shuttles to the nucleus, where it is proposed to
function in splicing39, an interesting possibility is that the two
shuttling proteins interact in the nucleus or even shuttle together.
By promoting translation, Xrn1 will then favour co-translational
targeting of mRNAs to the ER. Alternatively, Xrn1 may assist
mRNA localization at the ER by a translation-independent
mechanism. Once at the ER and after several rounds of transla-
tion, the mRNAs would then be co-translationally degraded by
Xrn1.
We propose that the Xrn1-mediated crosstalk between tran-
scription, translation, and decay involves the decaysome complex.
The decapping activators Lsm1–7, Pat1, and Dhh1 shuttle to the
nucleus in an Xrn1-dependent manner, associate to chromatin
and stimulate transcription1. Likewise, these decapping activators
are required for the function of Xrn1 in translation. Lsm1–7,
Pat1, and Dhh1 are required for BMV RNA2 translation and the
DEAD-box RNA helicase Dhh1 activates translation of cellular
mRNAs13 that signiﬁcantly overlap with those translationally
activated by Xrn1 (p-value= 1 × 10−5, Hypergeometric test).
However, our data support that each factor carries a distinct non-
overlapping function that complements each other. For example,
Lsm1–7/Pat1-requirements for BMV RNA translation are related
to sequences within the 3ʹUTR40,41, Dhh1-requirement to
sequences within the 5ʹ and 3ʹ UTRs and CDS13 and Xrn1-
requirement primarily to sequences within the 5ʹUTR (this
study).
Collectively, our data provide mechanistic details of the func-
tion of Xrn1 in translation activation and uncover an Xrn1-
mediated crosstalk between the three major stages in gene
expression. A key area for future research will be in elucidating
how the transitions between the subsequent Xrn1 functions are
regulated and responsive to the environment.
Methods
Yeast cultures. Yeast cells were grown in synthetic complete medium (SC) at
30 °C. Galactose (2%) was used as carbon source and it also served as inductor for
GAL1-directed viral RNA expression. After transformation, three colonies for each
condition were selected and streaked on a selective media plate. Cells were grown
over-day in selective liquid media and diluted to grow overnight. Next day, they
were diluted and grown until the doubling time between triplicates was similar and
an OD600 of ~0.6 was reached. Yeast strains and plasmids are listed in Supple-
mentary Data 7.
Cloning of Xrn1 derivative strains. Xrn1-AID strain was generated by ampliﬁ-
cation of the cassette present in BYP7427 plasmid with Xrn1-speciﬁc primers. The
PCR product was puriﬁed and transformed in BY25598 strain and plated in
minimal media with corresponding selection markers (−His,+Ade,+Leu,+Tryp).
Positive colonies were selected by checking the correct integration of the AID
cassette in Xrn1 and were subsequently sequenced.
Xrn1 D208A strain was generated by the following strategy. First, XRN1 gene
was ampliﬁed and cloned in pSZ229 using Fw-Xrn1–250-AgeI and Rv-Xrn1+ 110-
AcI primers. Second, this plasmid was transformed in BY4741 xrn1Δ strain and
plated in+G418+His selective plates for homologous recombination to occur.
Third, colonies were tested by PCR to ensure recombination had occurred in the
right locus and subsequently sequenced. All primers and strains are listed in
Supplementary Data 7 and Supplementary Data 8.
Cloning of Xrn1 derivative plasmids. The plasmids generated for this study were
cloned following conventional molecular cloning strategies. In order to be able to
select for all plasmids used in this study, we changed the selection markers of
plasmids pAJ37 and pAJ22819 by URA3 marker, and we named the plasmids
pBBM1 and pBBM3, respectively. Xrn1 D208A mutant plasmid (pBBM2) was
generated using the KOD Hot Start DNA polymerase from Millipore.
pLCM2 was generated by inserting one single copy of a FLAG-tag
(GATTACAAGGATGACGACGATAAG) in the 3ʹ end of pBBM2. To increase our
signal, we inserted two more copies in pLCM2, generating a 3xFLAG (GATTAC
AAGGATGACGACGATAAGGACTATAAGGACGATGACGACAAAGATTAT
AAAGACGACGATGACAAG) Rat1ΔNLS plasmid (pLCM6). All the experiments
done along this study have been performed with pLCM6 and we refer to it as
Rat1ΔNLS-FLAG plasmid. pLCM7 was generated by taking out the 3xFLAG from
pLCM6 and introducing it in the 3ʹ end of pBBM1 plasmid.
Rat1ΔNLS-XC-FLAG chimera (pLCM9) was generated by fusing the N-
terminal domain (1–884 aminoacids) of Xrn1 in pBBM3 to the C-terminal domain
(733–1528 aminoacids) of Rat1ΔNLS in pLCM7. Also, we depleted a loop in the
CDS of Rat1ΔNLS (Δ24–42 aminoacids) because it was hampering the interaction
between the N-terminal and the C-terminal domains of the chimera.
Rat1ΔNLS-XC-D235A-FLAG mutant plasmid (pLCM22) was generated using
the KOD Hot Start DNA polymerase from Millipore.
All the plasmids and primer sequences used in this study are listed in
Supplementary Data 7 and 8.
BMV RNA translation assay. To evaluate BMV protein translation, yeast cells
were transformed with the corresponding plasmids and grown as speciﬁed in the
previous section. Two OD units (Optical Density units) were harvested for protein
extraction and three OD units for total RNA extraction.
Total protein was extracted from equivalent number of cells and loaded on an
sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) gel to be
separated according to their molecular weight. Next, samples were immunoblotted
into a nitrocellulose membrane for 90 min at 100 V on ice, as previously
described42. Antibodies against 2a protein15, GFP, PGK (Molecular Probes), and
Xrn1 (gift from Arlen Johnson) were used (Supplementary Data 9). Detection of 2a
protein was done with FUJIFILM Luminiscent Image Analyzer LAS-1000. For the
rest of proteins, the infrared imaging system Odyssey (LI-COR Biosciences) was
used.
Total RNA from yeast cells was isolated by a hot-phenol method, concentration
was measured with a Nanodrop device and 3 µg of total RNA were loaded on
formaldehyde denaturing agarose gels for subsequent northern blot analysis43.
MAXIscript in vitro transcription kit (Ambion) was used to generate probes that
speciﬁcally detect RNA2, GFP RNA, and 18S RNA. The generation of these probes
by in vitro transcription was based on previously described plasmids42,44,45.
Northern blots were developed by exposure to PhosphorImager screens and
imaging on a Typhoon 8600 (Amersham). Quantiﬁcation was carried out by
measuring band intensity using the ImageQuant software (Molecular Dynamics).
Protein turnover assay. Yeast cells transformed with a plasmid encoding for
RNA2-Rluc reporter (pJJ-16) were grown as described in Yeast Cultures section.
When they reached an OD600 of 0.5, protein synthesis was stopped with 0.5 mg/ml
cycloheximide. Renilla luciferase activity assay (Dual-Glo®, Promega) was used
following the protocol provided by the manufacturer. Samples were collected at
different intervals during 3 h by directly transferring 10 µl of culture to 100 µl of 1x
Passive Lysis Buffer. Only 10 µl of the lysate were used (the rest was stored at
−80 °C) and 200 µl of LARII-StopGlo solution (1:1) was subsequently added. FB12
Luminometer was employed to read Luciferase activity, with 5 s of equilibration
time and 5 s of measurement time. The values obtained were corrected by the
corresponding OD600 and were represented relatively to the ﬁrst time-point (t= 0).
This protocol was adapted from ref. 46.
RNA ligase-mediated (RLM)-Rapid ampliﬁcation of cDNA ends (RACE). To
characterize the 5′ terminus of the BMV RNA2, total RNA obtained by phenol
extraction was used to perform 5ʹ RNA Ligase-mediated (RLM) rapid ampliﬁcation
of complementary DNAs (cDNAs) ends using a FirstChoice RLM-RACE Kit
(Thermo Fisher Scientiﬁc) following manufacturer’s instructions. For the outer 5ʹ
RLM-RACE PCR, 5ʹ RACE outer primer and gene-speciﬁc primer (5ʹ-CATTTGT
TGGACGGTGTCGCAA-3ʹ) were used. One thousand dilution of the above-
mentioned PCR was used to amplify a nested PCR fragment with a 5ʹ RACE inner
primer and a gene-speciﬁc primer (5ʹCTCCTATCTCCAAGGGCGCTAT 3ʹ).
Polysome proﬁling. Cultures were grown from OD600= 0.02 to an OD600= 0.5 in
YPD media (Formedium) at 30 °C. In order to stabilize elongating ribosomes, cells
were treated with cycloheximide (CHX, 100 µg/ml ﬁnal concentration) during 1
min with manual shaking at room temperature. Cells were quickly harvested with a
vacuum ﬁltration system, scraped out of the ﬁlter and immediately frozen in liquid
nitrogen with 500 μl of lysis buffer (20 mM Tris-HCl (pH= 7.5), 100 mM NaCl, 5
mM MgCl2, 1% Triton X100, 0.5 mM DTT, 100 μg/ml CHX). Cells were lysed with
the Freezer/Mill (SPEX SamplePrep) with two cycles of 2 min at 5 cps with a 2 min
cooling-down step in between. Cell lysates were thawed at 30 °C for 1 min and
centrifuged at 3000 × g and 4 °C for 3 min. The soluble fraction was transferred to
new tubes and centrifuged at 10,000 × g and 4 °C for 5 min. After quantiﬁcation,
aliquots of 12 UA260 were made and stored at −80 °C. Linear gradients of 10–50%
sucrose were prepared in 50 mM Tris-HCl (pH= 7.5), 50 mM NH4Cl, 12 mM
MgCl2, 0.5 mM DTT, 100 μg/ml CHX. The Gradient Master (Biocomp) was used
for making the gradients in 14 × 89 mm polyallomer tubes (331372, Beckman
Coulter). One aliquot of 12 UA260 was loaded on each gradient and centrifuged in a
Beckman SW41 rotor at 209,490 × g and 4 °C for 3 h. Gradients were fractionated
with fraction collector Model 2128 (Biorad). These fractions were used for hot-
phenol RNA extraction or TCA protein precipitation and analyzed by northern
blot or western blot, respectively.
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Co-immunoprecipitation. Yeast cells carrying genomic GFP-tag fusions of either
eIF4G, eIF4E, or eIF4A were transformed with Xrn1, Rat1ΔNLS, and Rat1ΔNLS-
XC FLAG-tagged plasmids and were grown (400 ml culture) in exponential phase
until an OD600~0.6 was reached. They were harvested by centrifugation (5 min,
1811 × g, 20 °C) and lysed by vortexing with glass beads (four cycles of 30 s and
four cycles of 1 min) in lysis buffer (50 mM Tris-HCl (pH= 7.5), 150 mM NaCl,
0.1% NP-40, 1 mM EDTA and protease inhibitors). After recovering the soluble
fraction, total protein amount was measured by Pierce TM BCA Protein Assay Kit
(ThermoFisher). As a control for the input sample, 100 μg of total protein were
kept. For the immunoprecipitation, 3 mg of total protein were used. Samples were
measured in the Nanodrop and 1.12 U RNaseI/10 AU260 were added in the RNase-
treated samples. These were incubated for 1 h at 22 °C with inversion mixing every
10 min. In the meantime, untreated samples were kept at 4 °C.+/– RNase-treated
protein extracts were then incubated with 15 µl of GFP-trap_A beads (Chromotek)
for 1 h at 4 °C shaking in a rotating mixer. Three washes with 500 µl of wash buffer
(10 mM Tris-HCl (pH= 7.5), 200 mM NaCl, 0.5 mM EDTA, 1 mM PMSF, Pro-
tease inhibitor Cocktail) were performed and beads were pelleted in-between by
centrifugation (2500 × g, 2 min, 4 °C). Beads were resuspended in 20 µl of wash
buffer and 10 µl of 3x loading dye were added. Samples were eluted from the beads
by boiling at 95 °C for 5 min. The antibodies used are listed in Supplementary
Data 9.
RNA stability assay. Yeast cells transformed with the desired plasmid were grown
in selective SC media with 2% galactose, as described in the Yeast Cultures section.
Cultures of 50 ml were inoculated and were grown until they reached exponential
growth and an OD600 of 0.7. Three OD units were harvested by centrifugation
(1500 × g, 4 °C, 3 min) and frozen directly in liquid nitrogen. The rest of the yeast
culture was centrifuged simultaneously and the media was exchanged with new
pre-warmed media containing 2% glucose, in order to shut-off the transcription of
BMV RNA2. Samples of three OD units were harvested at different time-points
(15, 25, and 60 min) and frozen. Total RNA extraction and northern blot analysis
were performed.
Translation assay upon Xrn1 auxin-induced degradation. A yeast strain with an
integrated TIR1 was used for the generation of a genomic fusion of Xrn1 to an
auxin-induced degron (AID). Together with TIR1, this fusion enabled the quick
degradation of Xrn1 protein upon addition of auxin, taking advantage of a protein
degradation pathway in plants18.
Yeast cells transformed with BMV RNA2-Rluc plasmid were grown in SC
media with 2% rafﬁnose until they reached exponential phase and an OD600~0.5 in
50 ml cultures. Galactose (2%) and auxin (500 µM) were added to induce BMV
RNA2-Rluc expression and deplete Xrn1, respectively. Samples were taken at
different time-points for OD measurement, Luciferase activity assay and total RNA
extraction. BMV RNA2-Rluc was quantiﬁed by reverse transcription quantitative
PCR using TaqMan probes and the qScript XLT One-Step RT-qPCR ToughMix
(Quanta Biosciences).
Ribosome proﬁling. Ribosme proﬁling experiments were performed essentially as
described in ref. 47. Yeast cells were grown, harvested, and lysed as described in the
Polysome Proﬁling section. In the case of ribosome-proﬁling, 10 OD260 units of
lysates were treated with 112.5 U of RNaseI (Ambion) for 60 min at 22 °C and
1400 rpm in the Thermomixer. RNaseI activity was stopped by addition of 100 U of
SUPERaseIn (Ambion) and digested extracts were loaded in 7–47% sucrose gra-
dients. The preparation of gradients followed the same protocol as in polysome
proﬁling, but in this case SUPERaseIn was added to the gradients as well (10 U/ml)
Ultracentrifugation was performed for 3 h at 209,627.4 × g and 4 °C in a TH-641
rotor (Thermo Scientiﬁc). The fractionation of gradients was performed with a
Density Gradient Fractionating System (Brandel) at a rate of 0.75 ml/min.
Monosomal fractions corresponding to digested polysomes were collected, SDS to
1% was added to stop any possible RNase activity and samples were ﬂash-frozen in
liquid nitrogen and stored at −80 °C. RNA was isolated from monosomal fractions
using the hot acid-phenol method. Ribosome-protected fragments (RPFs) were
isolated by running 15% polyacrylamide, 8 M urea, 1X TBE gels and isolating RNA
fragments of 28–32 nucleotides (nt). For RNAseq, 150 µl of the same lysate were
used for total RNA extraction with the hot acid-phenol protocol and subsequent
TURBO DNase treatment (Ambion). Total RNA was quantiﬁed and 100 μg were
used for two rounds of puriﬁcation with the Poly(A)Purist MAG kit (Ambion).
Next, the puriﬁed mRNA was fragmented by alkaline hydrolysis in 50 mM sodium
bicarbonate (pH= 9.2) and 1 mM EDTA for 20 min at 95 °C. The RNA was
puriﬁed by ethanol precipitation and fragments of 50–80 nt were selected on a 15%
polyacrylamide, 8 M urea, 1 × TBE gel. The ligation of the 3ʹ-adapter was per-
formed for 4 h at 22 °C with 200,000 U of T4 RNA ligase 2 (truncated, NEB), 25%
PEG 8000 and 10 U of SUPERase In.
Genomic run-on. Genomic Run-On (GRO) was done in biological triplicates
essentially following the protocol described in ref. 48. We used the same number
(5 × 108) exponentially growing yeast cells (OD600= 0.5) for each run-on reaction.
Another aliquot of the same cells was used directly for RNA extraction, which
subsequently was used for cDNA synthesis using 33P-dCTP. GRO samples
provided nascent transcription rates (nTR) for every yeast gene. Then, they were
corrected by average cell volume (the median of the population measured by a
Coulter Counter device) for times 0 and 30 min after auxin addition to obtain
mRNA synthesis rates (SR). Whole RNA polymerase II transcriptome SR was
obtained by summing up all individual genes SR data. Transcriptome data (mRNA
levels, RA) were obtained from the hybridization of labeled cDNA onto nylon
ﬁlters. Total mRNA concentration in yeast cells was determined by quantifying
polyA+ in total RNA samples by oligo-dT hybridization of a dot-blot following the
protocol described49 and dividing by average cell volume. mRNA half-lives (HL) in
arbitrary units for every mRNA were obtained by dividing individual RA values by
SR ones1.
Ribosome-proﬁling analysis. Ribosome-proﬁling reads were aligned to the sac-
Cer3 transcriptome (SGD annotation) with bowtie50 using the following settings:
“-S -t -p 30 -n 1 -m 1 -l 25 –norc.” The transcriptome consisted of all CDS ﬂanked
by 18 nt of genomic sequence on either side (representing the UTR). Reads
mapping to the ﬁrst 63 nucleotides (18 nt 5ʹ UTR+ 15 codons) were discarded to
remove cycloheximide-induced artefacts. After codon assignment and quantiﬁca-
tion (analogous to ref. 13), raw per gene counts were supplied to the Riborex R-
package v1.2.323 to identify signiﬁcant differences of translational regulation upon
Xrn1 knock-down (minMeanCount= 0; FDR < 0.05). As Riborex only provides a
fold change estimate for the interaction between condition (t0 vs. t30) and tech-
nique (mRNA vs. RPF), all signiﬁcant genes were grouped according to their
behavior relative to the diagonal (=no change of translational control) by obtaining
the corresponding DESeq251 moderated log2 fold changes for mRNA and RPF
samples separately (as displayed in Fig. 5b). To simplify subsequent analyses, we
considered genes whose mRNA log2 fold change was smaller than ± 0.433 (ana-
logous to ref. 13) to have buffered/stable levels of mRNA.
Gene ontology enrichment analysis for the resulting groups was performed
using gProﬁleR52 with settings “correction_method= ‘‘fdr’’ and “hier_ﬁltering
= ‘‘moderate’”. For visualization, we used REViGO to deﬁne redundant GO terms
(http://revigo.irb.hr/) and only considered the top 5 non-dispensable terms.
For the metagene coverage analysis, per codon RPF counts were normalized by
gene length and library size (observed/expected) before being averaged per
condition. The averaged normalized footprints were then corrected by the
corresponding mRNA fold change relative to t0. Visualization was done using the
ggplot2 R-package53.
Analysis of PARS scores. Nucleotide resolution PARS scores for yeast RNAs were
obtained from GitHub (https://github.com/abelew/prfdb/tree/master/pars/
sce_Score.tab) and further processed using the statistical programming language R.
For a high resolution analysis of the region surrounding the translation initiation
site (TIS) we extracted up to 100 nt of the 5ʹ UTR (if available) as well as the ﬁrst
300 nt of the coding sequence (CDS) and plotted the mean (na.rm= TRUE) PARS
proﬁles for all the groups studied. PARS scores were also averaged across the
5ʹUTR, CDS and 3ʹUTR in order to compare increased or decreased RNA structure
in certain RNA regions between the different groups. Unless speciﬁed otherwise, a
Wilcoxon-Mann–Whitney test was used to detect signiﬁcant differences in all
analyses.
Structure modeling of the chimera Rat1ΔNLS-XC. The sequences of Rat1ΔNLS
and Xrn1 were aligned with the sequences of template structures of S. pombe and
K. lactis taken from the Protein Data Bank (PDB)54, with codes 3FQD and 3PIF,
respectively. We superposed both structures with MATCHMAKER, using CHI-
MERA55, and detected that the structure of Rat1 deviates from Xrn1 at the position
of Arg 653 in chain A of 3FQD, which corresponds to position 884 in the sequence
of Rat1, and this was selected for merging both the sequences.
The N-terminal domains of both structures are very similar. However, we
detected a protruding loop on the structure of Rat1 that collided with the C-
terminal domain of Xrn1 (between Ile19 and Gln25 positions in chain A of 3PIF,
corresponding to positions Val21 and Pro45 in chain A of 3FQD, aligned with the
sequence LEEQPQIVDGVIL of Rat1ΔNLS, see Supplementary Fig. 7). This loop
was removed from the sequence to construct the chimera sequence and test its
foldability. The chimera sequence merged Rat1ΔNLS and Xrn1, which was aligned
with the sequences of the templates (3FQD and 3PIF) using Clustalw56. The
structure was modeled with MODELLER57 and optimized with Rosetta58.
Cellular fractionation for mRNA recruitment analysis. Xrn1-AID strain was
grown in YPD with 2% glucose at 30 °C until the doubling time between triplicates
was similar and an OD600 of ~0.5 was reached. Ten ODs of the culture were
harvested (=WT). In the remaining culture the degradation of Xrn1 was induced
for 30 min by adding auxin to a ﬁnal concentration of 0.5 mM. After 30 min, cells
(10 ODs) were harvested by centrifugation. To analyze the RNA distribution
between cytoplasm and membrane fractions 240 µl of lysis buffer (50 mM MOPS,
275 mM potassium glutamate, 5 mM Mg Acetate and freshly added 100 µg/ml
CHX, 1 mM DTT, 20 U/ml Superasein and Roche protease inhibitor) were added
to ten ODs of frozen yeast pellet. Cells were lysed cryogenically by mixer milling in
a Retsch MM400 at 30 Hz 2 min (four times). The lysate was thawed at 25 °C and
centrifuged 10 min at 13,400 × g. The supernatant, corresponding to the cytoplasm,
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was transferred to a new eppendorf tube and triton was added to 0.1%. The pellet
was resuspended in lysis buffer containing 1% triton and homogenized in a dounce
homogenizer. After centrifugation (10 min 13,400 × g) the supernatant contains the
membrane fraction. RNA extraction was carried out using the hot-phenol method.
mRNA distribution between cytosol and membrane fraction was analyzed by
reverse transcription quantitative (q)PCR using TaqMan probes and qScript XLT
One-Step RT-qPCR Though Mix from Quanta Biosciences. Twelve nanograms of
total RNA were loaded and ampliﬁed using speciﬁc primers. The list of primers is
available in Supplementary Data 8.
Electroporation of in vitro transcribed RNA2-Rluc. The
protocol used is an adaptation of the one previously described59. Reporter RNAs
(RNA2-Rluc and pLucA) were in vitro transcribed from a plasmid using the
MAXIscript T7 In Vitro Transcription Kit (Ambion) and the MAXIscript T3 In
Vitro Transcription Kit (Ambion), respectively. The transcripts were subsequently
capped with ScriptCap™ m7G Capping System (CELLSCRIPT). Their integrity was
evaluated with a denaturing formaldehyde gel. After quantiﬁcation with a Nano-
drop device, RNAs were aliquoted and stored at −80 °C.
Yeast cells (wt and xrn1Δ) were treated with lyticase to remove the cell wall and
incubated with Sorbitol 1 M. Next, the spheroplasts were incubated with YAPD-
Sorbitol 1 M for 90 min at 30 °C to allow cell recovery. Finally, cells were pelleted,
resuspended with Sorbitol 1 M, and kept on ice. Electroporation cuvettes (0.2 cm
electrode gap, BioRad, Hercules) were kept on ice and RNA2-Rluc and pLucA RNA
were added (8 and 0.5 µg, respectively). Yeast spheroplasts were pipeted (180 µl)
into the cuvette and pulsed immediately (Bio_rad gene pulser II: 800 V, 25
µFaraday and 1000Ω, 20–25 ms). Spheroplasts were transferred to ice-cold 2 ml
tubes and placed at 30 °C with gentle swirling. After 30 min, cells were pelleted (3
min, 1500 × g), the supernatant was discarded and the pellets frozen immediately in
liquid nitrogen (stored at −80 °C). For measurement, cells were resuspended in 50
µl of 1X reporter lysis buffer (Renilla Luciferase activity assay, Dual-Glo®,
Promega) and vortexed vigorously for 30 s. Cell lysate (20 µl) and 50 µl of luciferase
assay substrate were mixed and measured immediately.
Statistical information. All the statistical information is detailed throughout the
Figure legends and the methods section.
Reporting summary. Further information on experimental design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
A reporting summary for this Article is available as a Supplementary Information ﬁle.
Ribosome Proﬁling and Genomic Run-On (GRO) raw data are available under accession
GSE109734 and GSE123326 at Gene Expression Omnibus (GEO). The source data
underlying Figs. 1–5, 7, and Supplementary Figs. 1–2, 3–8, 12 are provided as a Source
Data ﬁle.
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